Report overview
Clotrimazole Vaginal Tablets are antifungal topical medications used for the treatment of vulvovaginal pseudomycosis, especially for Candida albicans infections. A course of one tablet can last for 72 hours of efficacy. It is generally recommended to rinse the vaginal secretions before use and insert Clotrimazole Vaginal Tablets deep in the vagina, best used at night before going to bed.
This report contains market size and forecasts of Clotrimazole Vaginal Tablet in Global, including the following market information:
Global Clotrimazole Vaginal Tablet Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Clotrimazole Vaginal Tablet market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
100mg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Clotrimazole Vaginal Tablet include Bayer, Perrigo, Facmed Pharmaceuticals Private Limited, Stort Pharmaceutical, Lagaay Medical BV, CR Double-Crane, YABANG Pharma, Jiangsu Kanion Pharmaceutical Co.,Ltd. and Zhejiang Sanbikom Pharmaceutical Co.,Ltd., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clotrimazole Vaginal Tablet companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clotrimazole Vaginal Tablet Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Clotrimazole Vaginal Tablet Market Segment Percentages, by Type, 2022 (%)
100mg
150mg
500mg
Others
Global Clotrimazole Vaginal Tablet Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Clotrimazole Vaginal Tablet Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacies
Clinics
Others
Global Clotrimazole Vaginal Tablet Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Clotrimazole Vaginal Tablet Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clotrimazole Vaginal Tablet revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clotrimazole Vaginal Tablet revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Perrigo
Facmed Pharmaceuticals Private Limited
Stort Pharmaceutical
Lagaay Medical BV
CR Double-Crane
YABANG Pharma
Jiangsu Kanion Pharmaceutical Co.,Ltd.
Zhejiang Sanbikom Pharmaceutical Co.,Ltd.
Nanjing Yewin Pharmaceutical Co.,Ltd.
Venturepharm Group Inc.
Jinan Limin Pharmaceutical Co.,Ltd.
South Ocean Pharmaceutical
Hainan Bikai Pharmaceutical Co.,Ltd.
Disha Pharmaceutical Group Co.,Ltd.
